FINANCIAL TRUST COMPANY INC ACCT. W23560001
For the Period 8/1112 to 8/31/12
Note: ** Unrealized Gain/Loss is shown as "N/A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan team for additional
information.
Equity Detail
Adjusted Tax Cost Unrealized Est. Annual Inc.
Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield
US Large Cap Equity
ARIAD PHARMACEUTICALS INC 20.58 16,535.000 339,959.60 251,475.52 88,484.08
04033A-10-0 ARIA
BIOGEN IDEC INC 148.59 2,095.000 307,108.05 250,454.95 58,651.10
09062X-10-3 8116
FACEBOOK INC-A 18.06 17,500.000 318,015.00 666,000.00 (348,985.00)
30303M-10-2 FB
GS CONT BUFF ED SPX 719113 102.18 3,000,000.000 3,085,370.00 3,000,000.00 65,370.00
80% CONTIN BARRIER- 10.5%CPN
15% CAP
INITIAL LEVEL-6/20/12 SPX:1355.69
38143U-Z9-5
HSBC MARKET PLUS SPX 06117113 102.68 5,000,000.000 5,134,000.00 5,000,000.00 134,000.00
72% KO BARRIER- 0%CPN
.UNCAPPED
INITIAL LEVEL-02/14/12 SPX:1350.50
4042K1-XC1-1
Total US Large Cap Equity $9.162,450.65 8946030.47 (84,47922) $0.00 0.00%
JP Morgan Account W23560001 Page 5 of 36 Consolidated Statement Page 8
Confidential Treatment Requested by JPMorgan JPM-SDNY-00016212
Chase
CONFIDENTIAL SDNY_GM_00285410
EFTA01493362